68.20.Z - Rental and operating of own or leased real estate
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
46.90.Z - Non-specialised wholesale trade
52.10.B - Warehousing and storage of other goods
63.99.Z - Other information service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0 | 0 | -44,1 |
EBITDA | 0,2 | 0,1 | 0,1 | 2 |
Short time liabilities | 0,5 | 0,4 | 0,3 | -29,2 |
Equity capital | 6,1 | 6,1 | 6,1 | 0 |
Operating profit (EBIT) | 0,1 | 0 | 0 | -77,4 |
Assets | 6,5 | 6,4 | 6,3 | -1,7 |
Net profit (loss) | 0 | 0 | 0 | -79,1 |
Cash | 0,4 | 0,4 | 0,2 | -40,7 |
Net income from sale | 2,1 | 2,3 | 2,4 | 7,6 |
Liabilities and provisions for liabilities | 0,5 | 0,4 | 0,3 | -29,2 |
Working assets | 0,9 | 0,5 | 0,4 | -27,4 |
Depreciation | 0,1 | 0,1 | 0,1 | 7,6 |
% | % | % | p.p. | |
Profitability of capital | 0,8 | 0,1 | 0 | -0,1 |
Equity capital to total assets | 92,6 | 94,1 | 95,8 | 1,7 |
Gross profit margin | 2,5 | 0,1 | 0,1 | 0 |
EBITDA Margin | 7,6 | 5,2 | 4,9 | -0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 83 | 62 | 40 | -22 |
Current financial liquidity indicator | 1.8078553676605225 | 1.2866791486740112 | 1.3194212913513184 | 0 |
Net dept to EBITDA | -2.6859982013702393 | -3.4448306560516357 | -2.003046989440918 | 1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane